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Abstract
Background: Tuberculous meningitis is common in developing countries and accounts for about
7.8% to 14% of all cases of tuberculosis in Nigeria.
Case presentation: Case 1 was a 17-year-old woman who presented with a 3-week history of
weakness of the right upper and lower limbs, a 6-hour history of inability to speak and irrational
behaviour. She had no remarkable past medical history. Physical examination revealed pyrexia
(temperature of 38.2°C) and altered level of consciousness (Glasgow coma score = 7/15). The signs
of meningeal irritation were present and she had anisocoria and right spastic hemiparesis. Other
aspects of physical examination were normal. Laboratory investigations showed an elevated
erythrocyte sedimentation rate, normal cerebrospinal fluid protein and reduced glucose. The brain
computed tomography scan showed features in keeping with obstructive hydrocephalus and she
was immediately commenced on antituberculous drugs, intravenous steroids and mannitol. She
made a remarkable clinical recovery and was discharged home 6 weeks after admission. Case 2 was
a 40-year-old man who presented with a 6-week history of headache and fever and a 2-week
history of alteration in level of consciousness. There was no history of neck pain and/or stiffness,
nausea or vomiting. He had no other remarkable past medical history. He had been placed on
various intravenous antibiotics in private hospitals before presentation, with no clinical
improvement. Physical examination showed a young man in a coma (Glasgow coma score = 4/15)
and febrile (temperature of 38.5°C) with signs of meningeal irritation. The brain stem reflexes were
impaired and he had spastic quadriparesis. Further physical examination was essentially normal. The
cerebrospinal fluid analysis showed features in keeping with meningeal inflammation and he had a
raised erythrocyte sedimentation rate. The brain computed tomography scan showed features in
keeping with obstructive hydrocephalus. He was placed on antituberculous drugs and intravenous
steroids but despite this his clinical condition deteriorated and he died on the sixth day after
admission.
Conclusion: Late presentation of tuberculous meningitis is not rare in Nigerians and we report
two cases of tuberculous meningitis that presented late to our health care facility. This report is
intended to make clinicians aware of the unusual clinical presentations of tuberculous meningitis.
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Background
It is estimated that over one-third of the world's popula-
tion has been infected with Mycobacterium tuberculosis, and
that over 70,000 individuals have tuberculous meningitis
(TBM) [1]. In many areas of Africa and Asia, the annual
incidence of tuberculosis (TB) infection for all ages is
approximately 2% and about 15% to 20% of these cases
occur in children. TBM complicates about 1 in 300 of
every untreated cases of TB globally, and in Nigeria it
accounts for about 7.8% to 14% of all cases of TB [2,3].
Nigerian patients may present late to the hospital and may
show atypical clinical and laboratory features [4] which
may be misdiagnosed, potentially leading to a high rate of
morbidity and mortality in these patients. In this article
we report two patients with TBM who presented late to
our hospital after receiving treatments from various health
facilities with no clinical improvement. This report is
intended to increase clinician awareness of late and atyp-
ical presentation of TBM.
Case presentation
Case 1
A 17-year-old Nigerian woman of Yoruba ethnic origin
had been managed for non-specific abdominal pain in the
previous 18 months but later defaulted from clinical fol-
low-up. She presented to our unit with a 3-week history of
weakness of right upper and lower limbs and a 6-hour his-
tory of inability to talk and irrational behaviour. There
was associated anorexia, vomiting, fever, neck stiffness
and photophobia. She had no seizures or blurring of
vision. There was no history suggestive of respiratory, car-
diac or urinary abnormalities. There was no personal or
family history of hypertension, diabetes mellitus or sickle
cell disease. There was no history of blood transfusion,
she was not sexually active and her gynaecological history
was normal.
On admission, she was pyrexic (temperature of 38.2°C)
and a neurological examination revealed an unconscious
patient with a Glasgow coma score (GCS) of 7/15
(E2V2M3). She had neck stiffness, and Brudinzki's and
Kernig's signs were present. The pupils were bilaterally
dilated (6 mm) and were unresponsive to light. There was
no papilloedema but she had right facioparesis (upper
motor neurone type) and right spastic hemiparesis. Apart
from tachycardia (pulse rate of 152 beats per minute),
other aspects of physical examination were essentially
normal.
Initial investigations showed an erythrocyte sedimenta-
tion rate (ESR) of 112 mm/hour (Westergren method).
Cerebrospinal fluid (CSF) examination showed normal
CSF protein (40 mg/dl) and reduced CSF glucose (1.8
mml/l). The random blood glucose (RBG) was normal
(5.2 mml/l) and the CSF to blood glucose ratio was
reduced (< 0.5). The CSF microscopy, culture and sensitiv-
ity were negative and no acid-fast bacilli were isolated
from the CSF. The retroviral screening was negative and
chest X-ray showed right middle and lower zone consoli-
dation. A brain computed tomography (CT) scan showed
moderate dilatation of all ventricles with associated visu-
alizations of the temporal horns of the left lateral ventricle
in keeping with early obstructive hydrocephalus. There
was also meningeal enhancement with contrast injection.
The patient was started on antituberculous drugs, that is,
rifampicin, isoniazid, ethambutol pyrazinamide and
intravenous steroids. Mannitol was also given as adjuvant
therapy to relieve the raised intracranial pressure. By the
fourth week of admission the patient had made excellent
clinical response to antituberculous drugs; her GCS had
improved to 15/15 and she had regained full muscle
power globally. She was placed on pilocarpine and
instructed by the ophthalmologists to wear dark specta-
cles because of her dilated pupils.
Case 2
A 40-year-old Nigerian man of Yoruba ethnic origin pre-
sented with 6-week history of throbbing and generalized
headache and high-grade continuous fever. Two weeks
before presentation he developed an altered level of con-
sciousness which was initially confusion and irrational
behaviour. He lapsed into unconsciousness a week before
presentation. He had lost a considerable amount of
weight in the 2 weeks before presentation; however, there
was no history of cough, chest pain or night sweating. He
had no renal, cardiac or gastro-intestinal symptoms. There
was no personal or family history of hypertension, diabe-
tes mellitus or sickle cell disease. He had no history of risk
factors for retroviral illness. He had been treated in vari-
ous private hospitals with no clinical improvement. On
admission the patient was chronically ill-looking, cachec-
tic, pale and febrile (temperature of 38.5°C). The neuro-
logical examination revealed an unconscious young man
with GCS of 4/15 (E1V2M1) with neck stiffness but absent
Kernig's and Brudzinski's signs.
There was anisocoria with a left pupil diameter of 4 mm
and a right pupil diameter of 2 mm, and both were unre-
active to light. The brain stem reflexes were present but
motor examination showed global loss of muscle bulk
with spastic quadriparesis (power grade 2 globally). Chest
examination showed tachypnoea (respiratory rate of 22
cycles per minute)) and widespread transmitted sounds in
the chest. Other aspects of physical examination were nor-
mal.
Initial investigations showed an ESR of 100 mm/hour
(Westergren method). The CSF analysis showed CSF pro-
tein of 87 mg/dl and CSF glucose of 70 mg/dl. RBG wasCases Journal 2008, 1:180 http://www.casesjournal.com/content/1/1/180
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106 mg/dl and the CSF to RBG ratio was greater than 0.5.
CSF showed numerous red blood cells per high-power
field and less than five white blood cells (WBCs) per high-
power field. The serum electrolyte, urea and creatinine
showed mild azotaemia with urea of 12.1 mmol/l and cre-
atinine of 127 μmol/l while other electrolyte parameters
were within normal ranges. Retroviral screening, per-
formed on two occasions, was negative. The haemogram
revealed a packed cell volume of 39% and WBC count was
11,000/mm3 with neutrophilia. A brain CT scan showed
features in keeping with obstructive hydrocephalus. There
was enhancement around the periventricular regions with
sulcal effacement (Figure 1).
The patient underwent surgery (ventriculostomy) to
relieve the hydrocephalus on the second day of admission
and about 200 to 250 ml of CSF was drained over the fol-
lowing 2 days, but his clinical condition deteriorated and
he died on the sixth day after admission in the intensive
care unit of the hospital. The autopsy study that was car-
ried out showed gelatinous exudates at the base of the
brain with severe oedema (Figure 2). The histology of the
smear of the exudates showed granulomatous inflamma-
tion with Langerhans cells.
Discussion
TBM begins as a primary infection of the lungs (through
inhalation) or rarely following the ingestion of infected
milk [5]. The bacteria may spread over several weeks to
infect the regional lymph nodes from where bacteraemia
may occur, and by haematogenous spread they invade the
meninges or the brain parenchyma forming the Rich focus
where they remain dormant for many years. With aging or
the development of immunosuppression the Rich focus
may be re-activated in the central nervous system causing
meningitis, meningoencephalitis or cerebral tubercu-
loma, depending on the initial site of the Rich focus in the
brain.
In TBM there is formation of gelatinous exudates which
settle at the base of the brain causing central nervous
pathologies via cerebral vasculitis (causing infarction or
haemorrhage), blockage of CSF pathways (hydrocepha-
lus) and entrapment of cranial nerves. The early symp-
toms of TBM are usually constitutional, for example fever
(low or high grade), malaise, headache, anorexia and
recent weight loss. Later the patient may present with
alteration in the level of consciousness (confusion to
frank coma). The patient may also present with hemipare-
sis, aphasia, multiple cranial nerve palsies, visual loss, sei-
zures (focal or generalized) or with choreiform limb
movement disorders. Usually the late symptoms develop
with the onset of complications. The history of onset of
illness is usually greater than 3 weeks and in a study
among Nigerian patients, the mean duration of illness
before presentation was 3.7 weeks. Other unusual presen-
tations such as generalized myoclonus, rigidity, hic-
coughs, retention of urine, gait ataxia and hearing
impairment were documented in some patients [4].
Brain computed tomography scan of case 2 showing dilated  ventricles and calcification of choroids plexus Figure 1
Brain computed tomography scan of case 2 showing 
dilated ventricles and calcification of choroids plexus.
The gross pathological findings of the brain of case 2 at  autopsy showing gelatinous exudates at the base of the brain Figure 2
The gross pathological findings of the brain of case 2 
at autopsy showing gelatinous exudates at the base 
of the brain. There is also associated brain oedema and 
congestion.Cases Journal 2008, 1:180 http://www.casesjournal.com/content/1/1/180
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Investigations that may help in the diagnosis of TBM
include full blood count and ESR, which may typically
show leukopenia and/or normal WBC count, but leukocy-
tosis and neutrophilia have been reported in some
patients with TBM. There may be anaemia with elevated
ESR (as in all of the cases reported). Electrolyte urea and
creatinine may show hyponatraemia due to development
of the syndrome of inappropriate antidiuretic hormone
secretion (SIADH) in about 45% of cases. In about 10%
of patients the urinalysis may show WBCs without signif-
icant bacteriuria, that is, sterile pyuria [6]. CSF was clear in
64%, turbid in 30% and xanthochromic in 8% while
spontaneous clotting occurred in 4% of patients in a study
in Nigeria [4]. CSF cell count may range from 30 to 1000
WBC/mm3, usually a mixture of lymphocytes and neu-
trophils, and predominantly polymorphonuclear pleocy-
tosis occurs in 15% of patients. CSF glucose is usually
lower than normal in 85% of cases while CSF protein may
be elevated, ranging from 60 mg/dl to 1 g/dl (see [7]). A
Nigerian study documented normal protein in about 6%
of patients, and acid-fast bacilli may be isolated from the
CSF in 5% to 30% of patients [4].
The tuberculin skin test may be negative in some patients
with co-morbid immunosuppressive illness, but immu-
nocompetent patients usually produce positive reactions
to the tuberculin test. Electroencephalographic studies
often show diffuse slowing, but in cases of cerebral infarc-
tion there may be focal slowing. Neuroimaging analysis
using brain CT scan with contrast, or magnetic resonance
imaging with gadolinium, is generally abnormal showing
meningeal enhancement consistent with meningeal
inflammation. Areas of infarction and haemorrhage may
also be seen in cases of TBM, while patients with late com-
plications may show hydrocephalus (as in both of the
cases reported here). Neuroimaging may also show the
presence of intracerebral tuberculoma. Meningeal calcifi-
cation may be obvious on skull X-ray while chest X-ray
may show pneumonic process, adenopathy, fibronodular
changes, cavitations and pleural effusion if there is associ-
ated tuberculous involvement of the lungs. Brain biopsy
may be performed at surgery in selected patients and spec-
imens subjected to histopathological studies, Ziehl Niel-
son stain, fungal studies and culture. The patient should
also be screened for immunodeficiency states such as ret-
roviral illness, diabetes mellitus and so on. The unusual
clinical and laboratory features such as the presence of
high-grade pyrexia (in both of our cases), the presence of
normal CSF protein (case 1), normal CSF glucose (case 2)
and presence of normal CSF microscopy culture and sen-
sitivity (in both of our cases) may lead to misdiagnosis or
late diagnosis of TBM with the attendant high rate of mor-
bidity and mortality.
Multiple drug treatment is required in the management of
TBM and the drugs should adequately cross the blood-
CSF barrier to achieve a therapeutic concentration in the
CSF. The first-line drugs are isoniazid, rifampicin, pyrazi-
namide, streptomycin and ethambutol while second line
anti-TB drugs that could be used include ofloxacin, cipro-
floxacin, capreomycin, kanamycin, cycloserine, amikacin,
clofazimine and rifabutin. The treatment duration is for 9
to 12 months but this could be extended to 18 to 24
months if there is poor treatment response. If multidrug
resistance occurs, second-line drugs should be used. In an
Egyptian study, drug resistance in CSF M. tuberculosis was
low [8]; resistance to isoniazid was 10%, ethambutol was
7%, and rifampicin was 3%; no CSF isolate was multidrug
resistant in that study. The incidence of CSF multidrug
resistance is higher in children, young adults, patients in
developing countries and patients infected with HIV.
The adjunctive therapies include intravenous steroids, for
example dexamethasone and oral steroids (pred-
nisolone), usually given in the first 1 to 2 months of ther-
apy to relieve the features of raised intracranial pressure
while patients with hydrocephalus will benefit from surgi-
cal intervention (ventriculoperitoneal or ventriculo-atrial
shunt procedure).
About 50% of TBM patients die and 15% may survive
with permanent neurological deficit, while 35% may
achieve a full clinical recovery or have minimal sequelae
[9]. The clinical stage at the time of presentation is the sin-
gle most important predictor of clinical outcome, and two
recent studies have shown that age, stage of disease, pres-
ence of cranial nerve deficit, presence of SIADH, abnor-
mality of electroencephalography, abnormality of motor-
evoked potentials and low GCS were associated with poor
clinical outcome [10].
Conclusion
Late presentation of TBM is not rare in our environment.
The presence of fever, headaches, recurrent seizures lasting
more than 2 to 3 weeks, poor response to conventional
antibiotics and the presence of focal neurological signs
such as hemiplegia, aphasia and multiple cranial nerve
palsies should raise suspicions of TBM in a patient who
has the symptoms and signs of meningeal irritation. Also,
the CSF findings may be atypical, and the presence of
obstructive hydrocephalus should further raise the suspi-
cion of the attending physician for TBM.
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